NaPro BioTherapeutics Inc., of Boulder, Colo., established a scientific advisory board for its genomics division: Chairman Robert Pollack, Eric Kmiec, Anthony Lechich, Malcolm Moore, Marc Ostro, Ethan Signer, John Weinstein and Nancy Wexler.
Novirio Pharmaceuticals Ltd., of Cambridge, Mass., appointed James Egan senior vice president, business and corporate development.
Orphan Medical Inc., of Minneapolis, added Pamela Stahl as vice president of commercial operations.
Pharmacyclics Inc., of Sunnyvale, Calif., appointed Timothy Whitten senior vice president of marketing and sales.
Schroder Venture Life Sciences, of London, appointed Graham Boulnois to its team in London and John Borzilleri and Jeffrey Vender to its team in Boston.
Tularik Inc., of South San Francisco, appointed Craig Saxton to its board.
ViroLogic Inc., of South San Francisco, promoted Tien Bui to vice president of sales and Karen Hartwig to vice president of marketing.
YM BioSciences Inc., of Mississauga, Ontario, appointed Henry Friesen to its board.
Zyomyx Inc., of Hayward, Calif., appointed Nicholas Naclerio senior vice president and chief business officer.